Patheon Inc. announces final court approval of arrangement

 TORONTO, March 10, 2014 /CNW/ - Patheon Inc. (TSX: PTI) ("Patheon") announced  today that the Ontario Superior Court of Justice (Commercial List) (the  "Court") has issued a final order approving Patheon's previously announced  statutory plan of arrangement (the "Arrangement") under the Canada Business  Corporations Act ("CBCA") pursuant to which JLL/Delta Patheon Holdings, L.P.  ("Newco"), which is sponsored by an entity controlled by an affiliate of JLL  Partners Inc. and Koninklijke DSM N.V., will indirectly acquire all of the  issued and outstanding restricted voting shares of Patheon. In issuing the  final order, the Court has determined that the Arrangement is fair and  reasonable in accordance with the requirements of the CBCA.  It is expected that the Arrangement will be completed on Tuesday, March 11,  2014, assuming the satisfaction or waiver of certain customary conditions.  About Patheon Inc.  Patheon Inc. is a leading provider of contract development and commercial  manufacturing services to the global pharmaceutical industry for a full array  of solid and sterile dosage forms. Through the company's recent acquisition of  Banner Pharmacaps - a market leader in soft gelatin capsule technology -  Patheon now also includes a proprietary products and technology business.  Patheon provides the highest quality products and services to approximately  300 of the world's leading pharmaceutical and biotechnology companies. The  company's integrated network consists of 15 locations, including 12 commercial  contract manufacturing facilities and 9 development centers across North  America and Europe. Patheon enables customer products to be launched with  confidence anywhere in the world. For more information visit www.patheon.com.  Forward-Looking Statements  This press release contains "forward-looking information" or "forward-looking  statements" within the meaning of applicable Canadian securities laws,  including statements regarding the proposed transaction and expected timing of  the transaction, which forward-looking statements may use forward-looking  terminology such as "may", "will", "expect", "anticipate", "believe",  "continue", "potential", or the negative thereof or other variations thereof  or comparable terminology. Such forward-looking statements may include,  without limitation, statements regarding the completion of the proposed  transaction and other statements that are not historical facts.  These forward-looking statements reflect beliefs and assumptions which are  based on Patheon's perception of current conditions and expected future  developments, as well as other factors management believes are appropriate in  the circumstances. Patheon's beliefs and assumptions may prove to be  inaccurate and consequently Patheon's actual results could differ materially  from the expectations set out herein.  While such forward-looking statements are expressed by Patheon in good faith  and believed by Patheon to have a reasonable basis, they are subject to  important risks and uncertainties including, without limitation, risks and  uncertainties relating to the transaction and financing thereof, and the  satisfaction or waiver of certain other conditions contemplated by the  arrangement agreement dated November 18, 2013 between Patheon and Newco. As a  result of these risks and uncertainties, the proposed transaction could be  modified, restructured or may not be completed, and the results or events  predicted in these forward-looking statements may differ materially from  actual results or events. These forward-looking statements are not guarantees  of future performance, given that they involve risks and uncertainties.  Patheon is not affirming or adopting any statements made by any other person  in respect of the proposed transaction and expressly disclaims any intention  or obligation to update or revise any forward-looking statements, whether as a  result of new information, future events or otherwise, except in accordance  with applicable securities laws or to comment on expectations of, or  statements made by any other person in respect of the proposed transaction.  Cautionary Statement  No stock exchange, securities commission or other regulatory authority has  approved or disapproved the information contained herein.    SOURCE  Patheon Inc.   Patheon Inc. Tel: (919) 226-3200 Email:investorrelations@patheon.com  To view this news release in HTML formatting, please use the following URL:  http://www.newswire.ca/en/releases/archive/March2014/10/c4248.html  CO: Patheon Inc. ST: Ontario NI: MTC